Outcome | Control group (n = 45) | Magnesium sulfate group (n = 45) | p value |
---|---|---|---|
Swelling ratio (%) | |||
 Postoperative day 1 | 103.2 ± 1.6 | 103.4 ± 2.1 | 0.625a |
 Postoperative day 2 | 105.1 ± 2.1 | 104.9 ± 2.1 | 0.631a |
 Postoperative day 3 | 105.1 ± 2.3 | 104.3 ± 1.8 | 0.058a |
Postoperative complications | |||
 Nausea | 12 (26.7%) | 9 (20.0%) | 0.455b |
 Vomiting | 10 (22.2%) | 6 (13.3%) | 0.270b |
 Wound complications | 5 (11.1%) | 3 (6.7%) | 0.711c |
 Chronic pain | 6 (13.3%) | 2 (4.4%) | 0.266c |
 Nerve damage | 0 (0) | 0 (0) |  |
 Postoperative infection | 0 (0) | 0 (0) |  |
 Venous thrombotic events | 0 (0) | 0 (0) |  |
 Significant decrease of quadriceps strength | 0 (0) | 0 (0) |  |
 Fall after surgery | 0 (0) | 0 (0) |  |
 3-month mortality | 0 (0) | 0 (0) |  |
 3-month readmission | 0 (0) | 0 (0) |  |